搜索临床试验以:SGLT2抑制剂
总计64324个结果
-
National Medical Research Center for Therapy and...招聘中
-
Hoffmann-La Roche完全的
-
CSL Behring完全的气肿 | Α 1 蛋白酶抑制剂缺乏症澳大利亚, 加拿大, 捷克共和国, 丹麦, 爱沙尼亚, 芬兰, 德国, 爱尔兰, 波兰, 罗马尼亚, 瑞典
-
Baxalta now part of ShireArriva Pharmaceuticals, Inc.完全的
-
Kamada, Ltd.完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eli Lilly and Company; Genentech, Inc.; Kazia Therapeutics Limited 和其他合作者招聘中
-
National Cancer Institute (NCI)主动,不招人复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性 3 级滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 3a 级滤泡性淋巴瘤美国, 加拿大, 新加坡
-
Rabin Medical CenterKamada, Ltd.完全的
-
Ottawa Hospital Research InstituteGlaxoSmithKline; Hamilton Health Sciences Corporation; London Regional Cancer Program, Canada; Ontario...完全的
-
Hoffmann-La Roche完全的
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials Limited招聘中
-
Grifols Therapeutics LLC终止
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte Corporation; H. Jean Khoury Cure CML Consortium招聘中
-
US Oncology ResearchBristol-Myers Squibb; Pfizer主动,不招人
-
Hunan Cancer HospitalSuzhou Sheng Diya Biomedical Co., Ltd.主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Weiyun AiCelgene Corporation完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Genentech, Inc.完全的
-
T. van der PollZonMw: The Netherlands Organisation for Health Research and Development; Prothya Biosolutions终止
-
Institute for Human Genetics and BiochemistryGrifols Biologicals, LLC; AIDS Community Research Initiative of America终止
-
University of Michigan Rogel Cancer CenterCSL Behring; The Leukemia and Lymphoma Society完全的
-
Medical Research CouncilNHS Health Technology Assessment Programme未知获得性免疫缺陷综合症 | 爱滋病毒感染
-
Christiana Care Health ServicesGlaxoSmithKline; Johnson & Johnson完全的
-
ANRS, Emerging Infectious DiseasesJanssen-Cilag Ltd.终止
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of Shire终止
-
University of Miami招聘中
-
University of CopenhagenHvidovre University Hospital招聘中
-
RenJi Hospital招聘中
-
Copenhagen University Hospital at Herlev未知
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.; Exelixis主动,不招人